Catechol O-methyltransferase pharmacogenomics: Human liver genotype-phenotype correlation and proximal promoter studies

Pharmacogenetics and Genomics

Volumn 19, Issue 8, 2009, Pages 577-587

  Zhang, Jianping ^a   Ji, Yuan ^a   Moon, Irene ^a   Pelleymounter, Linda L ^a   Ezequel Salavaggione, Oreste ^a   Wu, Yanhong ^b   Jenkins, Gregory D ^b   Batzler, Anthony J ^b   Schaid, Daniel J ^b   Weinshilboum, Richard M ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Catechol O methyltransferase; Genetic polymorphism; Haplotype; Single nucleotide polymorphism; Thermal stability

Indexed keywords

ALANINE; CATECHOL METHYLTRANSFERASE; COMPLEMENTARY DNA; DNA; GLYCINE; METHIONINE; VALINE;

ARTICLE; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; INTRON; LIVER; LIVER BIOPSY; PHARMACOGENOMICS; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOSTABILITY;

BIOPSY; CATECHOL O-METHYLTRANSFERASE; CELL LINE; CODON; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; LIVER; MODELS, GENETIC; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 68849113359     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32832c15c6     Document Type: Article

References (37)

1. Weinshilboum RM, Otterness DM, Szumlanski CL Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999; 39:19-52.
2. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223:1049-1059.
3. Lundstrom K, Tenhunen J, Tilgmann CTK, Panula P, Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1995; 1251:1-10.
4. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71:1296-1302.
5. Jeffery DR, Roth JA. Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex. J Neurochem 1984;42:826-832.
6. Weinshilboum RM, Raymond FA. Inheritance of low erythrocyte catechol O-methyltransferase activity in man. Am J Human Genet 1977; 29:125-135.
7. Scanion PD, Raymond FA, Weinshilboum RM. Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 1979; 203:63-65.
8. Weinshilboum R, Dunnette J. Thermal stability and the biochemical genetics of erythrocyte catechol-O-methyl-transferase and plasma dopamine-beta-hydroxylase. Clin Genet 1981; 19:426-437.
9. Boudíkovà B, Szumlanski C, Maidak B, Weinshilboum R. Human liver catechol O-methyltransferase pharmacogenetics. Clin Pharmacol Ther 1990;48:381-389.
10. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6:243-250.
11. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatr 2004; 9:151-160.
12. Lavigne JA, Helzlsouer KJ, Huang HY, Strickland PT, Bell DA, Selmin O, et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 1997;57:5493-5497.
13. Millikan RC, Pittman GS, Tse CK, Duell E, Newman B, Savitz D, et al. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis 1998; 19:1943-1947.
14. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 1998; 58:2107-2110.
15. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1 A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999; 59:4870-4875.
16. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, et al. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry 2005; 57:139-144.
17. Fabisch H, Kroisel PM, Fabisch K. Genetic risk factors in schizophrenia. Fortschr Neurol Psychiatr 2005;73(Suppl 1):S44-S50.
18. Mátyás T. Gene polymorphism and gene expression in schizophrenia. Psychiatr Hung 2006; 21:404-412.
19. Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry 2006; 60:141-151.
20. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314:1930-1933.
21. Ji Y, Salavaggione OE, Wang L, Adjei AA, Eckloff B, Wieben ED, et al. Human phenylethanolamine N-methyltransferase pharmacogenomics: gene resequencing and functional genomics. J Neurochem 2005; 95:1766-1776.
22. Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, Wang L, et al. Human aromatase: gene resequencing and functional genomics. Cancer Res 2005; 65:11071-11082.
23. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics 2006; 16:265-277.
24. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25:2745-2751.
25. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003; 300:949.
26. Raymond FA, Weinshilboum RM. Microassay of human erythrocyte catechol O methyltransferase: removal of inhibitory calcium ion with chelating resin. Clin Chim Acta 1975; 58:185-194.
27. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74:106-120.
28. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, et al. Choosing haplotype-tagging SN PS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 2003; 55:27-36.
29. Bell PA, Chaturvedi S, Gelfand CA, Huang CY, Kochersperger M, Kopla R, et al. SNPstream UHT: ultra-high throughput SNP genotyping for pharmacogenomics and drug discovery. Biotechniques 2002;74(Suppl 70-2):76-77.
30. Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005; 45:660-666.
31. Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, et al. Glutathione S-transferase P1: gene sequence variation and functional genomic studies. Cancer Res 2008; 68:4791-4801.
32. Ji Y, Olson J, Zhang J, Hildebrandt M, Wang L, Ingle J, et al. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res 2008; 68:5997-6005.
33. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-434.
34. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53:79-91.
35. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002; 2:S1-S15.
36. Axelrod J, Senoh S, Witkop B. O-Methylation of catechol amines in vivo. J Biol Chem 1958; 233:697-701.
37. Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958; 233:702-705.